Wednesday, October 27, 2021
HomeHealth5 things to know before the stock market opens Thursday, Oct. 14

5 things to know before the stock market opens Thursday, Oct. 14

Here are the most important news, trends and analysis that investors need to start their trading day:1. Stock futures rise after S&P 500, Nasdaq broke 3-day losing streaksTraders work on the floor of the New York Stock Exchange (NYSE), October 12, 2021.Brendan McDermid | Reuters2. Data on wholesale inflation, jobless claims out before the bellThe government was out with two key economics reports before Thursday’s Wall Street open: the September producer price index and initial jobless claims. First-time filings for unemployment benefits dropped to a Covid-era low of 293,000 for the week ended Oct. 9, fewer claims than expected. Headline PPI and core PPI, which excludes food, energy and trade, rose 8.6% and 5.9% from a year ago, respectively, similar to August’s year-over-year increases. Thursday’s wholesale inflation came after Wednesday’s elevated consumer inflation data. With price pressures mounting, the Social Security cost-of-living adjustment next year will be 5.9%, the biggest boost in about 40 years.3. Banks, health-related companies see shares rise on strong resultsThe pace of earnings season accelerated Thursday, with slew of banks reporting quarterly results before the bell and their shares moving higher in premarket trading.Dow stocks UnitedHealth and Walgreens Boots Alliance also reported better-than-expected earnings and revenue. Those stocks jumped in the premarket.4. FDA vaccine panel gets ready to consider Moderna, J&J boostersA registered nurse applies a dose of the Moderna COVID-19 vaccine to Sarasota Hospital worker Larry Hammers, 62, at the Sarasota Memorial Hospital in Sarasota, Florida, September 24, 2021.Shannon Stapleton | ReutersThe FDA’s vaccine advisory group meets Thursday to consider a booster for Moderna’s two-shot Covid regimen. FDA scientists on Tuesday declined to take a stance it. The agency’s panel then meets Friday to consider a booster for Johnson & Johnson’s one-dose vaccine and mix-and-match vaccine data. A highly anticipated NIH study, released Wednesday, suggests J&J recipients are better off getting a booster from Pfizer or Moderna. Also on Wednesday, the FDA said data provided by J&J suggests recipients may benefit from an additional dose. A booster of Pfizer’s two-shot vaccine was approved for certain groups of people last month.5. Foreclosures surge as Covid mortgage bailouts expirefstop123 | E+ | Getty ImagesForeclosures are starting to jump as government and private sector programs designed to help homeowners deal with the economic fallout of the Covid pandemic have begun to expire. Mortgage lenders began the foreclosure process on 25,209 properties in the third quarter, a 32% increase from the second quarter. On a year-over-year basis, it’s a 67% rise from the third quarter of 2020, according to Attom, a mortgage data firm. States with the largest number of new foreclosures were California, Texas, Florida, New York and Illinois.— Follow all the market action like a pro on CNBC Pro. Get the latest on the pandemic with CNBC’s coronavirus coverage.



image 100365595 14413751

RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Most Popular

Recent Comments